Nexalin Technology, Inc.
NXL- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001527352
No open-market purchases or sales by Nexalin Technology, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $281.6K in total; no superinvestor holds it.
Holders of 5% or more of NXL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Nexalin Technology, Inc., largest stake first. The change is against the holder's previous filing.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
2 Schedule 13D and 13G filings on Nexalin Technology, Inc., newest first, including old-format filings without a stake.
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Nexalin Technology, Inc. shares.
No Form 144 notices for Nexalin Technology, Inc. are on file.